期刊文献+

脑血管病医疗质量改进关键技术与体系的建立和应用——2020年度国家科学技术进步奖二等奖 被引量:2

Establishment and application of key technologies and systems for improving health care quality of cerebrovascular diseases——The Second Prize of 2020 National Science and Technology Progress
下载PDF
导出
摘要 脑血管病目前位居我国居民死亡和成人致残的首位病因,王拥军教授项目组以降低脑血管病复发率、致残率和病死率为目标,历时18年,研发了一整套基于影像特征、生物标志物和基因新指标的脑血管病精准治疗技术,使复发率相对下降37%~73%。同时,创立了以精准治疗技术等规范化应用为核心的医疗质量改进转化技术体系,可使脑血管病1年复发率相对下降28%,致残率相对下降26%,找到了医疗技术向临床转化的有效途径。团队还创建了集组织化管理模式、层级化质控架构和信息化数据平台于一体的脑血管病医疗质量改进体系,实现了实时监测和反馈医疗服务质量,该体系覆盖全国2497家医院,有效推动适宜诊疗技术向临床转化应用,使我国脑血管病医疗质量指标规范执行率相对提高21%,累计转化经费1.05亿元人民币。 Cerebrovascular disease is the first cause of adult disability and death at present in our country.The team led by Professor Wang Yongjun has developed a set of cerebrovascular disease treatment technology based on image feature,biological markers,and new gene indicators to reduce the recurrence rates,morbidity and mortality during 18 years,which has reduced the recurrence rate of cerebrovascular disease by 37%-73%relatively.Furthermore,the team has established an improvement and transformation technology system for medical quality,with the standardized application of precision treatment technology as the core.The one-year recurrence rate of cerebrovascular disease was reduced by 28%,and the disability rate by 26%.It means that they have explored an effective way of medical transformational technology into clinical practice.In addition,the team has integrated organizational management mode,hierarchical quality control framework and information data platform,real-time monitoring,and feedback of medical service quality into a medical quality improvement system of cerebrovascular disease,which covers 2497 hospitals across the country.It effectively promotes the transformation and application of appropriate diagnosis and treatment technologies into clinical practice.The standardized implementation rate of cerebrovascular disease medical quality index in China was increased by 21%.The accumulative conversion funds were 105 million Yuan.
作者 李子孝 赵性泉 王拥军 Li Zixiao;Zhao Xingquan;Wang Yongjun(Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing 100050, China)
出处 《首都医科大学学报》 CAS 北大核心 2022年第1期6-12,共7页 Journal of Capital Medical University
关键词 脑血管病 医疗质量 精准医疗 改进 cerebrovascular disease health care quality precision medicine improvement
  • 相关文献

参考文献3

二级参考文献8

  • 1WangYJ,LuDH,CuiLY ,etal.ProgressinNeurology[]..1999 被引量:1
  • 2BeijingNeurologistClub.BNCPracticeGuidelinesofCerebrovascularDiseases[]..2002 被引量:1
  • 3TheStrokeUnitTrialists’Collaboration.Collaborativesystematicreviewoftherandomisedtrialsoforganisedinpatient (strokeunit)careafterstroke[].British Medical Journal.1997 被引量:1
  • 4WarlowCP,DennisMS,vanGiinJ ,etal.Stroke:apracticalguidetomanagement[]..1996 被引量:1
  • 5.King’sFundConsensusConferenceTreatmentofstroke[].British Medical Journal.1988 被引量:1
  • 6Philippe D,Geert V,Andre P,et al.Proposal of guidelines for stroke units[].Acta Neurologica Belgica.2002 被引量:1
  • 7Jrgensen HS,Kammersgaard LP,Houth J,et al.Who benefits from treatment and rehabilitation in a stroke unit?:a community-based study[].Stroke.2000 被引量:1
  • 8Brott T,Bogousslavsky J.Treatment of acute ischemic stroke[].The New England Journal of Medicine.2000 被引量:1

共引文献627

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部